2,000 Shares in Metlife Inc (MET) Purchased by Farmers & Merchants Trust Co of Chambersburg PA

Farmers & Merchants Trust Co of Chambersburg PA acquired a new stake in shares of Metlife Inc (NYSE:MET) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,000 shares of the financial services provider’s stock, valued at approximately $85,000.

Several other hedge funds and other institutional investors also recently modified their holdings of MET. JNBA Financial Advisors acquired a new stake in shares of Metlife in the fourth quarter valued at $26,000. Bruderman Asset Management LLC acquired a new stake in shares of Metlife in the fourth quarter valued at $27,000. Berman Capital Advisors LLC acquired a new stake in shares of Metlife in the fourth quarter valued at $31,000. Executive Wealth Management LLC acquired a new stake in shares of Metlife in the fourth quarter valued at $34,000. Finally, Country Trust Bank increased its stake in shares of Metlife by 1,052.6% in the fourth quarter. Country Trust Bank now owns 876 shares of the financial services provider’s stock valued at $36,000 after buying an additional 800 shares in the last quarter. 76.85% of the stock is owned by institutional investors.

MET traded down $0.36 during midday trading on Monday, reaching $45.50. 87,949 shares of the company were exchanged, compared to its average volume of 5,406,563. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.26. Metlife Inc has a one year low of $37.76 and a one year high of $48.92. The stock has a market cap of $43.57 billion, a P/E ratio of 8.46, a price-to-earnings-growth ratio of 0.98 and a beta of 1.18.

Metlife (NYSE:MET) last issued its earnings results on Wednesday, February 6th. The financial services provider reported $1.35 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.05. Metlife had a return on equity of 10.24% and a net margin of 7.53%. The firm had revenue of $15.40 billion for the quarter, compared to analysts’ expectations of $15.84 billion. During the same quarter last year, the business earned $0.64 earnings per share. The company’s revenue was up .0% compared to the same quarter last year. As a group, equities analysts forecast that Metlife Inc will post 5.48 EPS for the current year.

In other Metlife news, CFO John D. Mccallion sold 2,669 shares of the firm’s stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $44.43, for a total transaction of $118,583.67. Following the transaction, the chief financial officer now owns 20,538 shares in the company, valued at $912,503.34. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Steven J. Goulart sold 10,292 shares of the firm’s stock in a transaction dated Tuesday, February 12th. The stock was sold at an average price of $44.40, for a total value of $456,964.80. Following the transaction, the executive vice president now owns 93,214 shares in the company, valued at approximately $4,138,701.60. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

A number of brokerages recently commented on MET. Royal Bank of Canada lowered their price objective on Metlife from $57.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, December 17th. Sandler O’Neill upgraded Metlife from a “hold” rating to a “buy” rating in a research report on Wednesday, January 2nd. Wells Fargo & Co reiterated a “buy” rating on shares of Metlife in a research report on Tuesday, January 8th. Bank of America upgraded Metlife from a “neutral” rating to a “buy” rating and set a $44.06 price objective for the company in a research report on Wednesday, January 16th. Finally, ValuEngine upgraded Metlife from a “sell” rating to a “hold” rating in a research report on Wednesday, January 16th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company. Metlife has a consensus rating of “Hold” and a consensus target price of $52.76.

TRADEMARK VIOLATION NOTICE: This news story was published by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.themarketsdaily.com/2019/04/15/2000-shares-in-metlife-inc-met-purchased-by-farmers-merchants-trust-co-of-chambersburg-pa.html.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: What are the Benefits of Index Funds?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.